Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
NCT05544214
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Type II Diabetes Mellitus
Interventions
DRUG:
CKD-371
Sponsor
Chong Kun Dang Pharmaceutical